Skip to main content

Pharmala Biotech Holdings Inc.(MDMA-CN)
CSE

Today's Change
Delayed Last Update

PharmAla Biotech ready to assist Alberta Government with Clinical MDMA supply

Newswire.ca - Thu Oct 6, 2022

The Government of Alberta's Announcement that they will legalize Psychedelic therapies brings both opportunity and risk

VANCOUVER, BC, Oct. 6, 2022 /CNW/ - PharmAla Biotech (CSE: MDMA), currently the only manufacturer of GMP MDMA in Canada, stands ready to assist the Government of Alberta in supplying patients with clinical-grade drug product. However, many questions remain about how the Alberta government intends to deliver psychedelic molecules to patients under this new framework.

Read more at newswire.ca

Provided Content: Content provided by Newswire.ca. The Globe and Mail was not involved, and material was not reviewed prior to publication.

More from The Globe